The impact of COVID-19 on cancer care: learning the lessons from the pandemic

24 November 2021 - Policy Dialogue organised in cooperation with AMGEN

Speakers: Antonella Cardone, CEO, European Cancer Patient Coalition; Greg Friberg, MD Vice President for Medical Affairs Europe, Latin America, Middle East, and Canada, Amgen; Johan de Munter, President, European Oncology Nursing Society; Tit Albreht, Senior Health Services and Health Systems Researcher, National Institute of Public Health of Slovenia

Moderator: Emma Woodford, Chief Operating Officer, European Policy Centre

The COVID-19 pandemic has had an unprecedented impact on our societies and economies, causing horrendous human suffering and significant socioeconomic consequences. Being subjected to an overwhelming rise in the demand for urgent care, all health services have been placed under severe strain. Each COVID-19 wave diverts resources away from patients with other healthcare needs such as cancer. Non-COVID-19 patients have faced service disruption, which too often result in delayed or missed diagnoses and, in worst cases, medical care has been foregone. Cancer patients are faced with significant challenges in terms of access to care during the pandemic and the added stress of visiting hospital alone due to visitor restrictions. The pandemic has also disrupted prevention programmes, screening and early detection services.

This Policy Dialogue discussed the impact of treatment delays and disruptions to the cancer care pathway, reflecting on lessons learnt from the COVID-19 pandemic for the future of cancer care while also focusing on the implementation of Europe’s Beating Cancer Plan.
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. More information is available in our Privacy Policy